Transient muscle paralysis degrades bone via rapid osteoclastogenesis

FASEB Journal

Volumn 26, Issue 3, 2012, Pages 1110-1118

  Aliprantis, Antonios O ^a,b   Stolina, Marina ^c   Kostenuik, Paul J ^c   Poliachik, Sandra L ^d   Warner, Sarah E ^d   Bain, Steven D ^d   Gross, Ted S ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c AMGEN INC   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Botulinum toxin A; Homeostasis; NFATc1; RANKL

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; RECOMBINANT OSTEPROTEGERIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; METAPHYSIS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PARALYSIS; PRIORITY JOURNAL; TRABECULAR BONE;

ANIMALS; BONE AND BONES; BONE RESORPTION; BOTULINUM TOXINS, TYPE A; CELL COUNT; FEMALE; GENE DELETION; HUMANS; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; OSTEOPROTEGERIN; PARALYSIS; QUADRICEPS MUSCLE; RANK LIGAND; RECOMBINANT PROTEINS; TIBIA; TIME FACTORS;

ANIMALIA;

EID: 84857753406     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-196642     Document Type: Article

References (74)

1. Garland, D. E., Adkins, R. H., and Stewart, C. A. (2008) Five-year longitudinal bone evaluations in individuals with chronic complete spinal cord injury. J. Spinal Cord Med. 31, 543-550
2. Cooper, C. (2010) Osteoporosis: disease severity and consequent fracture management. Osteoporos. Int. 21(Suppl. 2), S425-S429
3. Gracia-Marco, L., Vicente-Rodriguez, G., Casajus, J. A., Molnar, D., Castillo, M. J., and Moreno, L. A. (2011) Effect of fitness and physical activity on bone mass in adolescents: the HELENA study. Eur. J. Appl. Physiol. 111, 2671-2680
4. Rantalainen, T., Nikander, R., Daly, R. M., Heinonen, A., and Sievanen, H. Exercise loading and cortical bone distribution at the tibial shaft. Bone 48, 786-791
5. Sambrook, P. N., Kotowicz, M., Nash, P., Styles, C. B., Naganathan, V., Henderson-Briffa, K. N., Eisman, J. A., and Nicholson, G. C. (2003) Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J. Bone Miner. Res. 18, 919-924 (Pubitemid 37294977)
6. Geusens, P. (2009) Emerging treatments for postmenopausal osteoporosis - focus on denosumab. Clin. Interv. Aging 4, 241-250
7. Teitelbaum, S. L., and Ross, F. P. (2003) Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649 (Pubitemid 36917505)
8. Boyle, W. J., Simonet, W. S., and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342 (Pubitemid 40852708)
9. Kong, Y. Y., Yoshida, H., Sarosi, I., Tan, H. L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C. R., Lacey, D. L., Mak, T. W., Boyle, W. J., and Penninger, J. M. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323
10. Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., Boyle, W. J., and Simonet, W. S. (1998) osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260-1268 (Pubitemid 28213402)
11. Tanaka, S., Nakamura, K., Takahasi, N., and Suda, T. (2005) Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol. Rev. 208, 30-49 (Pubitemid 41746383)
12. Min, H., Morony, S., Sarosi, I., Dunstan, C. R., Capparelli, C., Scully, S., Van, G., Kaufman, S., Kostenuik, P. J., Lacey, D. L., Boyle, W. J., and Simonet, W. S. (2000) Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J. Exp. Med. 192, 463-474 (Pubitemid 30666247)
13. 2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol. Rev. 231, 241-256
14. Sitara, D., and Aliprantis, A. O. Transcriptional regulation of bone and joint remodeling by NFAT. Immunol. Rev. 233, 286-300
15. Aliprantis, A. O., Ueki, Y., Sulyanto, R., Park, A., Sigrist, K. S., Sharma, S. M., Ostrowski, M. C., Olsen, B. R., and Glimcher, L. H. (2008) NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J. Clin. Invest. 118, 3775-3789
16. Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E., and Takayanagi, H. (2005) Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261-1269 (Pubitemid 41586956)
17. Winslow, M. M., Pan, M., Starbuck, M., Gallo, E. M., Deng, L., Karsenty, G., and Crabtree, G. R. (2006) Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev. Cell 10, 771-782 (Pubitemid 43779111)
18. Udagawa, N., Takahashi, N., Jimi, E., Matsuzaki, K., Tsurukai, T., Itoh, K., Nakagawa, N., Yasuda, H., Goto, M., Tsuda, E., Higashio, K., Gillespie, M. T., Martin, T. J., and Suda, T. (1999) Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone 25, 517-523 (Pubitemid 29469457)
19. Shiotani, A., Shibasaki, Y., and Sasaki, T. (2001) Localization of receptor activator of NFkappaB ligand, RANKL, in periodontal tissues during experimental movement of rat molars. J. Electron Microsc. (Tokyo) 50, 365-369 (Pubitemid 32930753)
20. Kawai, T., Matsuyama, T., Hosokawa, Y., Makihira, S., Seki, M., Karimbux, N. Y., Goncalves, R. B., Valverde, P., Dibart, S., Li, Y. P., Miranda, L. A., Ernst, C. W., Izumi, Y., and Taubman, M. A. (2006) B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 169, 987-998 (Pubitemid 44411961)
21. Yoshinaga, Y., Ukai, T., Abe, Y., and Hara, Y. (2007) Expression of receptor activator of nuclear factor kappa B ligand relates to inflammatory bone resorption, with or without occlusal trauma, in rats. J. Periodontal Res. 42, 402-409
22. Frost, H. M. (1999) An approach to estimating bone and joint loads and muscle strength in living subjects and skeletal remains. Am. J. Hum. Biol. 11, 437-455
23. Zanchetta, J. R., Plotkin, H., and Alvarez Filgueira, M. L. (1995) Bone mass in children: normative values for the 2-20-year-old population. Bone 16, 393S-399S
24. Rauch, F., Bailey, D. A., Baxter-Jones, A., Mirwald, R., and Faulkner, R. (2004) The 'muscle-bone unit' during the pubertal growth spurt. Bone 34, 771-775 (Pubitemid 38581121)
25. Lewis, S. J., and Smith, P. E. (2001) Osteoporosis prevention in myasthenia gravis: a reminder. Acta Neurol. Scand. 103, 320-322 (Pubitemid 32368009)
26. Sayer, A. A., Syddall, H., Martin, H., Patel, H., Baylis, D., and Cooper, C. (2008) The developmental origins of sarcopenia. J. Nutr. Health Aging 12, 427-432
27. Castro, M. J., Apple, D. F., Jr., Staron, R. S., Campos, G. E., and Dudley, G. A. (1999) Influence of complete spinal cord injury on skeletal muscle within 6 mo of injury. J. Appl. Physiol. 86, 350-358 (Pubitemid 29046977)
28. Hansen, R. B., Biering-Sorensen, F., and Kristensen, J. K. (2007) Urinary calculi following traumatic spinal cord injury. Scand. J. Urol. Nephrol. 41, 115-119 (Pubitemid 46598096)
29. Warner, S. E., Sanford, D. A., Becker, B. A., Bain, S. D., Srinivasan, S., and Gross, T. S. (2006) Botox induced muscle paralysis rapidly degrades bone. Bone 38, 257-264 (Pubitemid 43165791)
30. Poliachik, S. L., Bain, S. D., Threet, D., Huber, P., and Gross, T. S. (2010) Transient muscle paralysis disrupts bone homeostasis by rapid degradation of bone morphology. Bone 46, 18-23
31. Stolina, M., Adamu, S., Ominsky, M., Dwyer, D., Asuncion, F., Geng, Z., Middleton, S., Brown, H., Pretorius, J., Schett, G., Bolon, B., Feige, U., Zack, D., and Kostenuik, P. J. (2005) RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis. J. Bone Miner. Res. 20, 1756-1765 (Pubitemid 41361876)
32. Takahashi, N., Udagawa, N., Tanaka, S., and Suda, T. (2003) Generating murine osteoclasts from bone marrow. Methods Mol. Med. 80, 129-144
33. Parfitt, A. M. (1983) Bone Histomorphometry: Techniques and Interpretation, CRC Press, Boca Raton, FL, USA
34. Bouxsein, M. L., Boyd, S. K., Christiansen, B. A., Guldberg, R. E., Jepsen, K. J., and Muller, R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Miner. Res. 25, 1468-1486
35. Rauch, F., and Hamdy, R. (2006) Effect of a single botulinum toxin injection on bone development in growing rabbits. J. Musculoskelet. Neuronal Interact. 6, 264-268 (Pubitemid 44650785)
36. Blouin, S., Gallois, Y., Moreau, M. F., Basle, M. F., and Chappard, D. (2007) Disuse and orchidectomy have additional effects on bone loss in the aged male rat. Osteoporos. Int. 18, 85-92 (Pubitemid 44885499)
37. Kwon, T. G., Park, H. S., Lee, S. H., Park, I. S., and An, C. H. (2007) Influence of unilateral masseter muscle atrophy on craniofacial morphology in growing rabbits. J. Oral Maxillofac. Surg. 65, 1530-1537
38. Libouban, H., Blouin, S., Moreau, M. F., Basle, M. F., Audran, M., and Chappard, D. (2008) Effects of risedronate in a rat model of osteopenia due to orchidectomy and disuse: densitometric, histomorphometric and microtomographic studies. Micron 39, 998-1007
39. Manske, S. L., Boyd, S. K., and Zernicke, R. F. (2010) Muscle and bone follow similar temporal patterns of recovery from muscle-induced disuse due to botulinum toxin injection. Bone 46, 24-31
40. Ausk, B. J., Huber, P., Poliachik, S. L., Bain, S. D., Srinivasan, S., and Gross, T. S. (2012) Cortical bone resorption following muscle paralysis is spatially heterogeneous. Bone 50, 14-22
41. Ausk, B. J., Huber, P., Srinivasan, S., Bain, S. D., and Gross, T. S. (2011) Initiation of trabecular bone resorption following transient muscle paralysis is site specific. In 56th Annual Meeting of the Orthopaedic Research Society p. 2260, Long Beach, CA, USA
42. Jaworski, Z. F., Duck, B., and Sekaly, G. (1981) Kinetics of osteoclasts and their nuclei in evolving secondary haversian systems. J. Anat. 133, 397-405 (Pubitemid 11022817)
43. Shaw, N. J., White, C. P., Fraser, W. D., and Rosenbloom, L. (1994) Osteopenia in cerebral palsy. Arch. Dis. Child. 71, 235-238 (Pubitemid 24298270)
44. Larson, C. M., and Henderson, R. C. (2000) Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J. Pediatr. Orthop. 20, 71-74 (Pubitemid 30013402)
45. Sievanen, H. Immobilization and bone structure in humans. Arch Biochem. Biophys 503, 146-152
46. Rucci, N., Rufo, A., Alamanou, M., and Teti, A. (2007) Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio. J. Cell. Biochem. 100, 464-473 (Pubitemid 46146094)
47. Saxena, R., Pan, G., Dohm, E. D., and McDonald, J. M. (2011) Modeled microgravity and hindlimb unloading sensitize osteoclast precursors to RANKL-mediated osteoclastogenesis. J. Bone Miner. Metab. 29, 111-122
48. Morey-Holton, E. R., and Globus, R. K. (2002) Hindlimb unloading rodent model: technical aspects. J. Appl. Physiol. 92, 1367-1377 (Pubitemid 34670888)
49. Prasad, J., Huber, P., Bain, S. D., and Gross, T. S. (2011) Diminished mechanical stimuli following transient muscle paralysis are not associated with acute trabecular bone loss. In 33rd American Society for Bone and Mineral Research p. SU0007, San Diego, CA, USA
50. Judex, S., Garman, R., Squire, M., Busa, B., Donahue, L. R., and Rubin, C. (2004) Genetically linked site-specificity of disuse osteoporosis. J. Bone Miner. Res. 19, 607-613 (Pubitemid 41071221)
51. Marenzana, M., De Souza, R. L., and Chenu, C. (2007) Blockade of beta-adrenergic signaling does not influence the bone mechano-adaptive response in mice. Bone 41, 206-215 (Pubitemid 47001820)
52. Tang-Liu, D. D., Aoki, K. R., Dolly, J. O., de Paiva, A., Houchen, T. L., Chasseaud, L. F., and Webber, C. (2003) Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution. Toxicon 42, 461-469 (Pubitemid 38366196)
53. Bain, S. D., Prasad, J., Huber, P., Nork, S., and Gross, T. S. (2009) Transient muscle paralysis blocks the osteogenic response to skeletal injury. J. Bone Miner. Res. 24, S96
54. Manni, E., Bagolini, B., Pettorossi, V. E., and Errico, P. (1989) Effect of botulinum toxin on extraocular muscle proprioception. Doc. Ophthalmol. 72, 189-198 (Pubitemid 19284875)
55. Hambleton, P. (1992) Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J. Neurol. 239, 16-20
56. Lang, A. M. (2003) Botulinum toxin type A therapy in chronic pain disorders. Arch. Phys. Med. Rehabil. 84, S69-73; quiz S74-65
57. Imai, S., Rauvala, H., Konttinen, Y. T., Tokunaga, T., Maeda, T., Hukuda, S., and Santavirta, S. (1997) Efferent targets of osseous CGRP-immunoreactive nerve fiber before and after bone destruction in adjuvant arthritic rat: an ultramorphological study on their terminal-target relations. J. Bone Miner. Res. 12, 1018-1027 (Pubitemid 27264214)
58. Serre, C. M., Farlay, D., Delmas, P. D., and Chenu, C. (1999) Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone 25, 623-629 (Pubitemid 29525427)
59. Mach, D. B., Rogers, S. D., Sabino, M. C., Luger, N. M., Schwei, M. J., Pomonis, J. D., Keyser, C. P., Clohisy, D. R., Adams, D. J., O'Leary, P., and Mantyh, P. W. (2002) Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience 113, 155-166 (Pubitemid 34786021)
60. Wright, D. E., Williams, J. M., McDonald, J. T., Carlsten, J. A., and Taylor, M. D. (2002) Muscle-derived neurotrophin-3 reduces injury-induced proprioceptive degeneration in neonatal mice. J. Neurobiol. 50, 198-208 (Pubitemid 34131051)
61. Zaidi, M., Chambers, T. J., Gaines Das, R. E., Morris, H. R., and MacIntyre, I. (1987) A direct action of human calcitonin gene-related peptide on isolated osteoclasts. J. Endocrinol. 115, 511-518 (Pubitemid 18003090)
62. Vignery, A., and McCarthy, T. L. (1996) The neuropeptide calcitonin gene-related peptide stimulates insulin-like growth factor I production by primary fetal rat osteoblasts. Bone 18, 331-335 (Pubitemid 26149344)
63. Cornish, J., Callon, K. E., Lin, C. Q., Xiao, C. L., Gamble, G. D., Cooper, G. J., and Reid, I. R. (1999) Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts. J. Bone Miner. Res. 14, 1302-1309 (Pubitemid 29368292)
64. Mori, T., Ogata, T., Okumura, H., Shibata, T., Nakamura, Y., and Kataoka, K. (1999) Substance P regulates the function of rabbit cultured osteoclast; increase of intracellular free calcium concentration and enhancement of bone resorption. Biochem. Biophys. Res. Commun. 262, 418-422 (Pubitemid 29429883)
65. Goto, T., Kido, M. A., Yamaza, T., and Tanaka, T. (2001) Substance P and substance P receptors in bone and gingival tissues. Med. Electron. Microsc. 34, 77-85
66. Togari, A. (2002) Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc. Res. Tech. 58, 77-84
67. Chenu, C., and Marenzana, M. (2005) Sympathetic nervous system and bone remodeling. Joint Bone Spine 72, 481-483 (Pubitemid 41821404)
68. Kostenuik, P. J., Bolon, B., Morony, S., Daris, M., Geng, Z., Carter, C., and Sheng, J. (2004) Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. Bone 34, 656-664 (Pubitemid 38393801)
69. Ominsky, M. S., Kostenuik, P. J., Cranmer, P., Smith, S. Y., and Atkinson, J. E. (2007) The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys. Osteoporos. Int. 18, 1073-1082 (Pubitemid 47020009)
70. Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., Nishina, H., Takeda, S., Takayanagi, H., Metzger, D., Kanno, J., Takaoka, K., Martin, T. J., Chambon, P., and Kato, S. (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823 (Pubitemid 47332572)
71. Kuhn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995) Inducible gene targeting in mice. Science 269, 1427-1429
72. Vickerman, L., Neufeld, S., and Cobb, J. (2011) Shox2 function couples neural, muscular and skeletal development in the proximal forelimb. Dev. Biol. 350, 323-336
73. Usas, A., and Huard, J. (2007) Muscle-derived stem cells for tissue engineering and regenerative therapy. Biomaterials 28, 5401-5406 (Pubitemid 47599647)
74. Singh, J. A. (2010) Botulinum toxin therapy for osteoarticular pain: an evidence-based review. Ther. Adv. Musculoskelet. Dis. 2, 105-118